APP and Alzheimer disease: Xiao et al. demonstrated both in vitro and in vivo AD models that exogenous expression of the lysosomal regulator TFEB stimulates lysosomal biogenesis accelerating APP degradation and, consequently, decreasing Aβ generation and amyloid plaques [178].